(Reuters) – German biopharmaceutical firm Immatics said on Thursday it plans to collaborate with British drugmaker GlaxoSmithKline (GSK) to develop immunotherapies targeting multiple cancer
Germany’s Immatics ties up with GSK to develop immunotherapies

Motorcyclist seriously injured in Saturday crash at busy Fargo intersection
4h ago
Fargo man arrested after climbing downtown tower
4h ago
Chiefs WRs Rashee Rice, Tyquan Thornton suffer injuries
3h ago
Oil climbs after Yemeni Houthis attack Saudi Aramco sites
3h ago
Packers LB Edgerrin Cooper likely done for season with Achilles tear
1h ago
US removes B-1 bombers from UK base amid security concerns
4h ago
